Anthony Maida
Chief Tech/Sci/R&D Officer presso ONCOTELIC THERAPEUTICS, INC.
Patrimonio netto: 39 806 $ in data 29/02/2024
Profilo
Anthony E.
Maida is a businessperson who founded BioConsul Drug Development Corp.
and who has been the head of 7 different companies.
Dr. Maida occupies the position of Chairman for Dendri Therapeutics, Inc. and Director & Chief Medical Officer at Oncotelic Therapeutics, Inc. Anthony E.
Maida is also on the board of Oncotelic, Inc. and Member of American Chemical Society, Member of American Society of Clinical Oncology, Member of American Association for Cancer Research, Member of The Society of Neuro-Oncology, Member of International Society for Biological Therapy of Cancer, Member of The American Association of Immunologists, Member of Society of Toxicology and Member of Society For Immunotherapy of Cancer.
In the past Dr. Maida held the position of Chairman of BioConsul Drug Development Corp., Chief Executive Officer of Trellis Bioscience, Inc., President & Chief Executive Officer of Replicon NeuroTherapeutics, Inc., Chief Financial Officer & Vice President for Lockheed Dataplan, Inc., Senior Vice President-Clinical Research at Northwest Biotherapeutics, Inc., Principal at Anthony Maida Consulting International, President & Chief Executive Officer for Jenner Biotherapies, Inc., President & Chief Executive Officer at CancerVax Corp., President & Chief Executive Officer for Cell Pathways, Inc., Chief Financial Officer & Vice President at Data Plan, Inc., VP-Clinical Research & GM-Oncology Worldwide at PharmaNet, Inc. and Senior Financial Controller at Lockheed Missiles & Space Co.
Dr. Maida received an undergraduate degree and a graduate degree from San Jose State University, an MBA and an undergraduate degree from Santa Clara University and a doctorate from the University of California.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
03/04/2023 | 1 137 314 ( 0.28% ) | 39 806 $ | 29/02/2024 |
Posizioni attive di Anthony Maida
Società | Posizione | Inizio |
---|---|---|
ONCOTELIC THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 11/05/2020 |
Oncotelic, Inc.
Oncotelic, Inc. BiotechnologyHealth Technology Oncotelic, Inc. develops a therapeutic platform for cancer treatments. It conducts registration trials for multiple cancer indications including pancreatic, melanoma, and glioblastoma. The company was founded by Vuong Trieu and Chulho Park and is headquartered in Agoura Hills, CA. | Director/Board Member | - |
The Society of Neuro-Oncology
The Society of Neuro-Oncology Miscellaneous Commercial ServicesCommercial Services The Society of Neuro-Oncology is a non-profit organization, which engages in the research, education, and collaboration for central nervous system tumors in children and adults. The company was founded on January 31, 1996 and is headquartered in Bellaire, TX. | Corporate Officer/Principal | - |
Dendri Therapeutics, Inc. | Chairman | 01/03/2003 |
Society of Toxicology
Society of Toxicology Miscellaneous Commercial ServicesCommercial Services The Society of Toxicology is an organization that unites 8,000 professionals in the field of toxicology from all over the world. The non-profit company is based in Reston, VA. The company's goal is to promote scientific advancements and provide support to toxicologists. | Corporate Officer/Principal | - |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
The American Association of Immunologists | Corporate Officer/Principal | - |
International Society for Biological Therapy of Cancer
International Society for Biological Therapy of Cancer Miscellaneous Commercial ServicesCommercial Services The International Society for Biological Therapy of Cancer operates as a professional society of influential scientists, academicians, researchers, clinicians, and government representatives. The non-profit company is based in Milwaukee, WI. | Corporate Officer/Principal | - |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Precedenti posizioni note di Anthony Maida
Società | Posizione | Fine |
---|---|---|
░ ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Anthony Maida
San Jose State University | Graduate Degree |
Santa Clara University | Undergraduate Degree |
University of California | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 6 |
---|---|
ONCOTELIC THERAPEUTICS, INC. | Health Technology |
SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
NORTHWEST BIOTHERAPEUTICS, INC. | Health Technology |
RANGE IMPACT, INC. | Health Technology |
ONCOSEC MEDICAL INCORPORATED | Health Services |
9 METERS BIOPHARMA, INC. | Health Technology |
Aziende private | 23 |
---|---|
Jenner Biotherapies, Inc.
Jenner Biotherapies, Inc. Miscellaneous Commercial ServicesCommercial Services Jenner Biotherapies, Inc. developed therapies for cancer patients. The company was headquartered in Walworth, WI. | Commercial Services |
Cell Pathways, Inc.
Cell Pathways, Inc. Pharmaceuticals: OtherHealth Technology Cell Pathways, Inc. develops and commercializes drugs for the prevention and treatment of cancer | Health Technology |
CancerVax Corp. | Commercial Services |
Trellis Bioscience, Inc.
Trellis Bioscience, Inc. BiotechnologyHealth Technology Trellis Bioscience, Inc. is discovers and develops novel human antibody therapeutics. It provides the discovery and development of therapeutic antibodies from human B cells. The firm develops the CellSpot antibody discovery platform, which enables the identification of antibodies directly from human blood. The company was founded by Lawrence Kauvar and Stote Ellsworth in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
PharmaNet, Inc.
PharmaNet, Inc. Medical DistributorsDistribution Services PharmaNet, Inc. researches and develops new drugs and provides clinical development & consulting services. Its services include strategic planning, data management, bio-statistics, site management, study monitoring, protocol/CRF design, project management, information technology, quality control and assurance and regulatory affairs. The company was founded in 1996 by Jeffrey P. McMullen and is headquartered in Princeton, NJ. | Distribution Services |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Commercial Services |
Sirion Therapeutics, Inc.
Sirion Therapeutics, Inc. BiotechnologyHealth Technology Sirion Therapeutics, Inc. provides biopharmaceutical products and services. It manufactures, develops and commercialize ophthalmic products for eye diseases. The company was founded by Barry Butler, Susan Benton, Philippe Boulangeat and Roger Vogel in November 2005 and is headquartered in Tampa, FL. | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
Dendri Therapeutics, Inc. | |
BioConsul Drug Development Corp. | |
The Society of Neuro-Oncology
The Society of Neuro-Oncology Miscellaneous Commercial ServicesCommercial Services The Society of Neuro-Oncology is a non-profit organization, which engages in the research, education, and collaboration for central nervous system tumors in children and adults. The company was founded on January 31, 1996 and is headquartered in Bellaire, TX. | Commercial Services |
International Society for Biological Therapy of Cancer
International Society for Biological Therapy of Cancer Miscellaneous Commercial ServicesCommercial Services The International Society for Biological Therapy of Cancer operates as a professional society of influential scientists, academicians, researchers, clinicians, and government representatives. The non-profit company is based in Milwaukee, WI. | Commercial Services |
The American Association of Immunologists | |
Society of Toxicology
Society of Toxicology Miscellaneous Commercial ServicesCommercial Services The Society of Toxicology is an organization that unites 8,000 professionals in the field of toxicology from all over the world. The non-profit company is based in Reston, VA. The company's goal is to promote scientific advancements and provide support to toxicologists. | Commercial Services |
Replicon NeuroTherapeutics, Inc. | |
Data Plan, Inc. | |
Glycometrix, Inc. | |
Lockheed Missiles & Space Co. | |
Anthony Maida Consulting International | |
Oncotelic, Inc.
Oncotelic, Inc. BiotechnologyHealth Technology Oncotelic, Inc. develops a therapeutic platform for cancer treatments. It conducts registration trials for multiple cancer indications including pancreatic, melanoma, and glioblastoma. The company was founded by Vuong Trieu and Chulho Park and is headquartered in Agoura Hills, CA. | Health Technology |
Lockheed Dataplan, Inc. | Miscellaneous |
Society For Immunotherapy of Cancer
Society For Immunotherapy of Cancer Miscellaneous Commercial ServicesCommercial Services The Society for Immunotherapy of Cancer (SITC) is an organization that advances the science, development, and application of immunotherapy to improve cancer patient outcomes. The non-profit company is based in Milwaukee, WI. SITC conducts policy and advocacy efforts on behalf of its members and the field. The Journal for Immunotherapy of Cancer (JITC) is the official open access, peer-reviewed online journal of SITC, featuring original research articles, literature reviews, position papers, and discussions on all aspects of tumor immunology and cancer immunotherapy. SITC also created a conceptual framework for potential value in phase III studies evaluating immunotherapy combinations. | Commercial Services |